Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
13.98
+0.50 (3.75%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Anika Therapeutics Employees
Anika Therapeutics had 288 employees as of December 31, 2024. The number of employees decreased by 69 or -19.33% compared to the previous year.
Employees
288
Change (1Y)
-69
Growth (1Y)
-19.33%
Revenue / Employee
$416,344
Profits / Employee
-$195,781
Market Cap
198.75M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
ANIK News
- 11 days ago - Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Anika Therapeutics, Inc. (ANIK) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Anika Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Anika Completes Divestiture of Parcus Medical - GlobeNewsWire
- 7 weeks ago - Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025 - GlobeNewsWire
- 7 weeks ago - Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference - GlobeNewsWire
- 4 months ago - Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 months ago - Anika To Participate in December 2024 Investor Conferences - GlobeNewsWire